125 related articles for article (PubMed ID: 25131659)
21. Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder.
Kramer MW; Waalkes S; Serth J; Hennenlotter J; Tezval H; Stenzl A; Kuczyk MA; Merseburger AS
Urol Int; 2011; 87(2):143-50. PubMed ID: 21757871
[TBL] [Abstract][Full Text] [Related]
22. Tutorial: multivariate statistical treatment of imaging data for clinical biomarker discovery.
Deininger SO; Becker M; Suckau D
Methods Mol Biol; 2010; 656():385-403. PubMed ID: 20680603
[TBL] [Abstract][Full Text] [Related]
23. Matrix-assisted laser desorption/ionization and nanoparticle-based imaging mass spectrometry for small metabolites: a practical protocol.
Sugiura Y; Setou M
Methods Mol Biol; 2010; 656():173-95. PubMed ID: 20680591
[TBL] [Abstract][Full Text] [Related]
24. Laser desorption-ionization of lipid transfers: tissue mass spectrometry imaging without MALDI matrix.
Vidová V; Novák P; Strohalm M; Pól J; Havlícek V; Volný M
Anal Chem; 2010 Jun; 82(12):4994-7. PubMed ID: 20491444
[TBL] [Abstract][Full Text] [Related]
25. Novel workflow for combining Raman spectroscopy and MALDI-MSI for tissue based studies.
Bocklitz T; Bräutigam K; Urbanek A; Hoffmann F; von Eggeling F; Ernst G; Schmitt M; Schubert U; Guntinas-Lichius O; Popp J
Anal Bioanal Chem; 2015 Oct; 407(26):7865-73. PubMed ID: 26374565
[TBL] [Abstract][Full Text] [Related]
26. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
28. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.
Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR
J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544
[TBL] [Abstract][Full Text] [Related]
29. Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer.
Bonnel D; Longuespee R; Franck J; Roudbaraki M; Gosset P; Day R; Salzet M; Fournier I
Anal Bioanal Chem; 2011 Jul; 401(1):149-65. PubMed ID: 21519967
[TBL] [Abstract][Full Text] [Related]
30. Strategies for managing multi-patient 3D mass spectrometry imaging data.
Vos DRN; Jansen I; Lucas M; Paine MRL; de Boer OJ; Meijer SL; Savci-Heijink CD; Marquering HA; de Bruin DM; Heeren RMA; Ellis SR; Balluff B
J Proteomics; 2019 Feb; 193():184-191. PubMed ID: 30343012
[TBL] [Abstract][Full Text] [Related]
31. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
[TBL] [Abstract][Full Text] [Related]
32. A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.
Boskamp T; Lachmund D; Oetjen J; Cordero Hernandez Y; Trede D; Maass P; Casadonte R; Kriegsmann J; Warth A; Dienemann H; Weichert W; Kriegsmann M
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):916-926. PubMed ID: 27836618
[TBL] [Abstract][Full Text] [Related]
33. Reduced membranous MET expression is linked to bladder cancer progression.
Kluth M; Reynolds K; Rink M; Chun F; Dahlem R; Fisch M; Höppner W; Wagner W; Doh O; Terracciano L; Simon R; Sauter G; Minner S
Cancer Genet; 2014 Apr; 207(4):147-52. PubMed ID: 24853099
[TBL] [Abstract][Full Text] [Related]
34. The use of mass spectrometry imaging to predict treatment response of patient-derived xenograft models of triple-negative breast cancer.
Mascini NE; Eijkel GB; ter Brugge P; Jonkers J; Wesseling J; Heeren RM
J Proteome Res; 2015 Feb; 14(2):1069-75. PubMed ID: 25553735
[TBL] [Abstract][Full Text] [Related]
35. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
[TBL] [Abstract][Full Text] [Related]
36. Applications of MALDI-MSI to pharmaceutical research.
Prideaux B; Staab D; Stoeckli M
Methods Mol Biol; 2010; 656():405-13. PubMed ID: 20680604
[TBL] [Abstract][Full Text] [Related]
37. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer.
Minner S; De Silva C; Rink M; Dahlem R; Chun F; Fisch M; Höppner W; Wagner W; Bokemeyer C; Terracciano L; Simon R; Sauter G; Wilczak W
Pathology; 2012 Aug; 44(5):448-52. PubMed ID: 22772340
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging.
Lou S; Balluff B; Cleven AHG; Bovée JVMG; McDonnell LA
J Am Soc Mass Spectrom; 2017 Feb; 28(2):376-383. PubMed ID: 27873216
[TBL] [Abstract][Full Text] [Related]
39. Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia.
Oezdemir RF; Gaisa NT; Lindemann-Docter K; Gostek S; Weiskirchen R; Ahrens M; Schwamborn K; Stephan C; Pfister D; Heidenreich A; Knuechel R; Henkel C
Clin Biochem; 2012 Jan; 45(1-2):7-11. PubMed ID: 21986590
[TBL] [Abstract][Full Text] [Related]
40. Tumor classification with MALDI-MSI data of tissue microarrays: A case study.
Mascini NE; Teunissen J; Noorlag R; Willems SM; Heeren RMA
Methods; 2018 Dec; 151():21-27. PubMed ID: 29656077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
